Simeonidis Simos 4
4 · Regulus Therapeutics Inc. · Filed Oct 15, 2019
Insider Transaction Report
Form 4
Simeonidis Simos
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-10-10+46,500→ 46,500 totalExercise: $0.64Exp: 2029-10-09→ Common Stock (46,500 underlying)
Footnotes (1)
- [F1]The options will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant or on the date of the Company's next annual shareholder meeting, whichever occurs first, subject to the Reporting Person's continuous service.